Loading... Please wait...

Dermatological Therapeutics: Global Markets

Price:
USD $4,850.00
ISBN/SKU #:
GB-HLC057A
Research Group:
BCC
Date of Publication:
January 2009
Select License:

Summary

This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined. Skin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology manufacturers and dermatologists rely on cosmetic applications and procedures for survival.

This study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers of dermatological therapeutics industry across the world.
 
This study introduces the readers to most skin disorders, and some common procedures. However, as regards analysis, this study limits itself to prescription and therapeutic drugs for dermatological disorders. Cosmetic and aesthetic procedures, aging disorders, and wound care, which feels are aspects covered in enough detail elsewhere, have not been covered. Further, nail and hair disorders have also not been reviewed.
 
Some procedures were described so as to provide an understanding of the alternative and complementary modes of treatment and their important role apart from prescription drug treatment in dermatological therapy.
 
Thus, recent developments in chemical peels, cryotherapy, ultraviolet, and laser therapy have been overviewed. The report discusses various topical and other dermatologic drugs.
 
Some industry participants and non-commercial dermatological organizations have been mentioned. The report ends with a brief discussion about significant, recent international market developments reported in various publications.


This report:

  • Provides a techno-commercial review of the global dermatological therapeutics industry
    Reviews current and emerging technologies, products and markets (including manufacturers and large buyers)
  • Analyzes key trends
  • Forecasts market metrics such as volume and value through 2013
  • Profiles significant stakeholders in the global industry, such as government regulatory authorities, as well as significant non-governmental interests/ initiatives
  • Conducts a patent analysis
  • Analyzes products and technologies in the above-mentioned segments across key markets
  • Profiles key industry participants in this sector
  • Includes estimates and projections for past and future, by volume and value.

TABLE OF CONTENTS

Chapter- 1: SUMMARY

SUMMARY TABLE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 ($ BILLIONS)
SUMMARY FIGURE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, 2008 AND 2013 (%)

Chapter- 2: OVERVIEW

HUMAN SKIN
TABLE 1 FUNCTIONS OF THE SKIN
SKIN DISORDERS
TABLE 2 DISORDERS OF THE SKIN
ACNE
TABLE 3 TYPES OF ACNE
ROSACEA
TABLE 4 TYPES OF ROSACEA
TABLE 5 DRUGS AND THEIR ACTION AGAINST ACNE AND ROSACEA
BACTERIAL INFECTIONS OF THE SKIN
TABLE 6 TYPES OF BACTERIAL INFECTIONS OF THE SKIN
TABLE 7 SOME PRESCRIPTION DRUGS PRESCRIBED TO TREAT BACTERIAL SKIN INFECTIONS
BENIGN SKIN GROWTHS OR TUMORS
TABLE 8 TYPES OF BENIGN SKIN GROWTHS OR TUMORS
TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT BENIGN SKIN GROWTHS
BULLOUS DISORDERS OR BLISTERING DISEASES
TABLE 10 TYPES OF BULLOUS DISORDERS
TABLE 11 SOME PRESCRIPTION DRUGS USED TO TREAT BULLOUS SKIN DISORDERS
SKIN CANCERS
TABLE 12 TYPES OF SKIN CANCERS
Types of Melanoma
Lentigo Maligna Melanoma
Superficial Spreading Melanoma
Nodular Melanoma
Acral-Lentiginous Melanoma
TABLE 13 SKIN CANCER INCIDENCE IN THE U.S.
TABLE 14 SOME PRESCRIPTION DRUGS USED TO TREAT CUTANEOUS CARCINOMAS
CORNIFICATION DISORDERS
Calluses and Corns
TABLE 15 TYPES OF CALLUSES AND CORNS
Ichthyosis or Dry Skin
TABLE 16 TYPES OF ICHTHYOSIS
Keratosis Pilaris
TABLE 17 TYPES OF KERATOSIS PILARIS
Sebaceous Cysts
Dermatitis
TABLE 18 TYPES OF DERMATITIS
TABLE 19 SOME DRUGS PRESCRIBED FOR DERMATITIS
Fungal Infections of the Skin
TABLE 20 TYPES OF FUNGAL INFECTIONS OF THE SKIN
TABLE 21 SOME DRUGS PRESCRIBED TO TREAT FUNGAL INFECTIONS OF THE SKIN
HYPERSENSITIVITY AND INFLAMMATORY DISORDERS
Acute Febrile Neutrophilic Dermatosis (Sweet’s Syndrome)
Drug Eruptions and Reactions
TABLE 22 TYPES OF DRUG REACTIONS AND TYPICAL CAUSATIVE AGENTS
Erythema Multiforme
TABLE 23 TYPES OF ERYTHEMA MULTIFORME
Erythema Nodosum
Granuloma Annulare
Panniculitis
Pyoderma Gangrenosum
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Bed Sore
Pityriasis Rosea
TABLE 24 SOME DRUGS PRESCRIBED TO TREAT HYPERSENSITIVITY AND INFLAMMATORY DISORDERS
PARASITIC INFECTIONS OF THE SKIN
TABLE 25 TYPES OF PARASITIC INFECTION OF THE SKIN
TABLE 26 SOME DRUGS PRESCRIBED TO TREAT PARASITIC INFECTIONS OF THE SKIN
PSORIASIS AND SCALING DISEASES
TABLE 27 TYPES OF PSORIASIS AND SCALING DISEASES
Psoriasis Treatment
PIGMENTATION DISORDERS
TABLE 28 TYPES OF PIGMENTATION DISORDERS
Birthmarks
Poison Ivy
TABLE 29 SOME PRESCRIPTION DRUGS FOR PIGMENTATION DISORDERS
REACTIONS TO SUNLIGHT
Aging
Actinic Keratoses
Skin Cancers
Photosensitivity
TABLE 30 TYPES OF PHOTOSENSITIVITY
Sunburn
SWEATING DISORDERS
TABLE 31 TYPES OF SWEATING DISORDERS
VIRAL SKIN DISEASES
TABLE 32 TYPES OF VIRAL SKIN DISEASES
TABLE 33 SOME DRUGS PRESCRIBED TO TREAT VIRAL DISEASES OF THE SKIN
COMMON DIAGNOSTIC TESTS FOR SKIN DISORDERS
DERMOSCOPY
PATCH TESTING
SKIN BIOPSY
CULTURE
PHOTOTESTS
MORBIDITY/PREVALENCE
TABLE 34 SKIN DISORDER MORBIDITY IN THE U.S. BY AGE AND CAUSE (THOUSANDS)
THERAPEUTIC PROCEDURES FOR THE SKIN
CANCER SURGERY
Excisional Biopsy to Remove Skin Cancer
Curettage and Electrocautery
Mohs Micrographic Surgery (MMS)
Wide Local Excision
Skin Grafting
Lymph Node Removal
CHEMICAL PEELS
CRYOTHERAPY/CRYOSURGERY
Ice Packs
Cold Gel Packs
Ice Immersion
Ice Massage
Vapocoolant Sprays
RADIOTHERAPY
CHEMOTHERAPY
Chemotherapy Creams
Chemotherapy into a Vein
LASER SURGERY
TABLE 35 SKIN CONDITIONS REQUIRING ONLY LASER SURGERY
Carbon Dioxide Laser
YAG Laser
Pulsed Dye Laser or Argon Laser
Excimer Laser
TABLE 36 ADVANTAGES AND DISADVANTAGES OF EXCIMER LASER
PHOTODYNAMIC THERAPY
TABLE 37 VARIOUS CANCERS TREATABLE BY PDT
Application in Dermatology
TABLE 38 VARIOUS SKIN DISORDERS TREATABLE BY PDT
Goeckerman Treatment
PUVA
Ultraviolet B Phototherapy
Broadband
Narrowband
TABLE 39 ADVANTAGES AND DISADVANTAGES OF UVB THERAPY
SCLEROTHERAPY

Chapter- 3: PRESCRIPTION DERMATOLOGICAL DRUGS

SYSTEMIC DRUGS
ACITRETIN
CLINDAMYCIN
ERYTHROMYCIN
CYCLOSPORINE
TABLE 40 ADVANTAGES AND DISADVANTAGES OF CYCLOSPORINE
METHOTREXATE
TABLE 41 ADVANTAGES AND DISADVANTAGES OF METHOTREXATE
THALIDOMIDE
SYSTEMIC ANTIBACTERIAL AGENTS
Antileprotic Drugs (Including Dapsone)
Antimalarial Drugs (Including Hydroxychloroquine)
SYSTEMIC ANTIFUNGAL AGENTS
SYSTEMIC ANTIHISTAMINES
SYSTEMIC ANTIPARASITIC AGENTS
SYSTEMIC ANTIPRURITIC AGENTS
SYSTEMIC ANTIVIRAL AGENTS
SYSTEMIC CORTICOSTEROIDS
SYSTEMIC INTERFERONS
SYSTEMIC RETINOID
OTHER SYSTEMIC DRUGS
6-Thioguanine
Hydroxyurea
Mycophenolate Mofetil
Sulfasalazine
BIOLOGICAL THERAPIES (BIOLOGICS)
Colchicine
CYTOTOXIC AND IMMUNOSUPPRESSIVE DRUGS
Retinoids
Hormones and Anti-Androgens
TOPICAL TREATMENTS
ACICLOVIR
TOPICAL RETINOIDS
ANTHRALIN
TABLE 42 ADVANTAGES AND DISADVANTAGES OF ANTHRALIN
COAL TAR
TABLE 43 ADVANTAGES AND DISADVANTAGES OF COAL TAR
CORTICOSTEROIDS
TABLE 44 ADVANTAGES AND DISADVANTAGES OF CORTICOSTEROIDS
TABLE 45 TOPICAL CORTICOSTEROIDS, 2004
RETINOID: TAZAROTENE
TABLE 46 ADVANTAGES AND DISADVANTAGES OF TAZAROTENE
VITAMIN D3: CALCIPOTRIENE
TABLE 47 ADVANTAGES AND DISADVANTAGES OF CALCIPOTRIOL
CAPSAICIN
TOPICAL MEDICATIONS IN CLINICAL TRIALS
MOISTURIZERS AND SCALE REMOVERS
TABLE 48 DRUG TREATMENTS FOR SKIN DISEASE INTRODUCED IN 2006

Chapter- 4: TECHNOLOGY REVIEW

EMERGING TECHNOLOGIES IN DERMATOLOGY
DNA MICROARRAY TECHNOLOGY IN DERMATOLOGY
ADVANCES IN THE TREATMENT OF VARICOSE VEINS
EMERGING TREATMENT OF ATOPIC DERMATITIS
EMERGING DRUGS FOR ICHTHYOSIS
PROGRESS IN THE MANAGEMENT OF ACNE
PLASMA SKIN REGENERATION TECHNOLOGY
TABLE 49 NEW TECHNOLOGIES IN DERMATOLOGY
PERMEATION ENHANCEMENT TECHNOLOGIES
Drug Permeation Enhancement via Buccal Route
Thiomatrix: Permeation Enhancement
Merrion’s Technology: Gastrointestinal Permeation Enhancement Technology (GIPET)
FIGURE 1 GASTROINTESTINAL PERMEATION ENHANCEMENT TECHNOLOGY
Transdermal Protein Delivery or Measurement Using Low-Frequency Sonophoresis
RADIOTHERAPY
External Radiotherapy
Conformal Radiotherapy
Intensity Modulated Radiotherapy
Internal Radiotherapy
Radioactive Implants
Radioactive Liquids
PLASMA SKIN REGENERATION

Chapter- 5: PATENT ANALYSIS

PATENT ISSUE TRENDS IN UNITED STATES
FIGURE 2 U.S. PATENT TRENDS, 1990–2001
TABLE 50 NUMBER OF U.S. PATENTS ISSUED, 2003 TO JULY 31, 2008
TABLE 51 COMPANIES AND NUMBER OF U.S. PATENTS FILED BY THEM, 2003 TO JULY 31, 2008
TABLE 52 RECENT DERMATOLOGY U.S. PATENTS
PATENT ISSUE TRENDS IN EUROPE
TABLE 53 EUROPEAN DERMATOLOGICAL PATENTS, 2003–JULY 2008
TABLE 54 RECENT PATENTS ISSUED BY THE EPO

Chapter- 6: INDUSTRY PARTICIPANT PROFILES

CHAPTER SEVEN: INDUSTRY PARTICIPANT PROFILES
MANUFACTURERS OF DERMATOLOGICAL DRUGS
AGI DERMATICS
ALLERGAN, INC.
AMGEN, INC.
ANACOR PHARMACEUTICALS
ANIKA THERAPEUTICS, INC.
ASTELLAS US, LLC
CHESTER VALLEY PHARMACEUTICALS, INC.
CORIA LABORATORIES, LTD.
CORIA LABORATORIES, LTD.
DERMIK LABORATORIES, INC.
DUSA PHARMACEUTICALS, INC.
EISAI, INC.
FERNDALE LABORATORIES, INC.
GALDERMA LABORATORIES
GENENTECH, INC.
ISOLAGEN, INC.
LEO PHARMA A/S
MEDICIS PHARMACEUTICAL CORP.
MEDIMETRIKS PHARMACEUTICALS, INC.
MERZ PHARMA UK, LTD.
NEOSIL, INC.
NYCOMED U.S., INC.
OBAGI MEDICAL PRODUCTS, INC.
ONSET THERAPEUTICS
ORTHONEUTROGENA
PIERRE FABRE PHARMACEUTICALS, INC.
PRIME PHARMACEUTICALS CORP.
QLT, INC.
QUINNOVA PHARMACEUTICALS
SCHERING-PLOUGH CORP.
SINCLAIR PHARMACEUTICALS
SKINMEDICA, INC.
STIEFEL LABORATORIES, INC.
SUMMERS LABORATORIES, INC.
SYNTOPIX GROUP, PLC
TRIAX PHARMACEUTICALS, LLC
VALEANT PHARMACEUTICALS INTERNATIONAL
VALEO PHARMA, INC.
WARNER CHILCOTT, LTD.
XOMA, LTD.
NON-COMMERCIAL ORGANIZATIONS
AFRICAN ASSOCIATION OF DERMATOLOGY
AMERICAN ACADEMY OF DERMATOLOGY (AAD)
AMERICAN BEHCET’S DISEASE ASSOC., INC.
AMERICAN CELIAC SOCIETY
AMERICAN HEMOCHROMATOSIS SOCIETY, INC.
AMERICAN LUPUS SOCIETY
AMERICAN SKIN ASSOCIATION, INC.
AMERICAN SOCIAL HEALTH ASSOC.
ARTHRITIS FOUNDATION
ASIAN DERMATOLOGICAL ASSOCIATION
ASSOCIATION OF PROFESSORS OF DERMATOLOGY
ATAXIA-TELANGIECTASIA CHILDREN’S PROJECT
BASAL CELL CARCINOMA NEVUS SYNDROME/GORLIN SYNDROME
BAY AREA LUPUS FOUNDATION
BLOOM’S SYNDROME REGISTRY
BRITISH ASSOCIATION OF DERMATOLOGISTS
CELIAC DISEASE FOUNDATION
CELIAC SPRUE ASSOCIATION/USA
CICATRICIAL ALOPECIA RESEARCH FOUNDATION
COALITION OF SKIN DISEASES
CORNELIA DE LANGE SYNDROME FOUNDATION, INC.
CUTANEOUS LYMPHOMA FOUNDATION
DERMATOLOGY FOUNDATION
DERMATOLOGY NURSES ASSOCIATION (DNA)
DERMATOPATHOLOGY FOUNDATION
DYSAUTONOMIA FOUNDATION, INC.
DYSTROPHIC EPIDERMOLYSIS BULLOSA
THE ECTODERMAL DYSPLASIA SOCIETY
EHLERS DANLOS NATIONAL FOUNDATION (EDNF)
EHLERS-DANLOS SYNDROME FOUNDATION
EUROPEAN ACADEMY FOR DERMATOLOGY AND VENEREOLOGY
EADV Administrative Office
THE EUROPEAN DERMATOLOGY FORUM
EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH
EUROPEAN UNION OF MEDICAL SPECIALISTS
FOUNDATION FOR ICHTHYOSIS AND RELATED SKIN TYPES (F.I.R.S.T.)
GLUTEN INTOLERANCE GROUP (DERMATITIS HERPETIFORMIS)
HEMOCHROMATOSIS RESEARCH FOUNDATION
HIDRADENITIS SUPPURATIVA FOUNDATION, INC.
HISTIOCYTOSIS ASSOCIATION OF AMERICA
INFLAMMATORY SKIN DISEASE INSTITUTE (ISDI)
INTERNATIONAL FOUNDATION FOR DERMATOLOGY
THE INTERNATIONAL LEAGUE OF DERMATOLOGICAL SOCIETIES OFFICE
INTERNATIONAL PEMPHIGUS PEMPHIGOID FOUNDATION
THE INTERNATIONAL SOCIETY OF DERMATOPATHOLOGY
KLIPPEL-TRENAUNAY SUPPORT GROUP
LUPUS FOUNDATION OF AMERICA, INC.
LYMPHOMA RESEARCH FOUNDATION
LYMPHOMATOID PAPULOSIS CENTRAL REGISTRY
MARFAN ASSOC. U.K.
THE MELANOMA RESEARCH FOUNDATION
MUSCULAR DYSTROPHY ASSOC.
MYOSITIS ASSOCIATION OF AMERICA (MAA)
NATIONAL ALOPECIA AREATA FOUNDATION (NAAF)
NATIONAL ATAXIA FOUNDATION
NATIONAL ECZEMA ASSOCIATION (NEA)
NATIONAL ECZEMA ASSOCIATION FOR SCIENCE AND EDUCATION
NATIONAL ECZEMA SOCIETY
NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY
NATIONAL FOUNDATION FOR ECTODERMAL DYSPLASIAS
NATIONAL FOUNDATION FOR VITILIGO AND PIGMENT DISORDERS
NATIONAL INCONITENTIA PIGMENTI FOUNDATION
NATIONAL MEDICAL ASSOC.
NATIONAL NEUROFIBROMATOSIS FOUNDATION
NATIONAL ORGANIZATION FOR ALBINISM AND HYPOPIGMENTATION (NOAH)
NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD)
THE NATIONAL PEMPHIGUS FOUNDATION
NATIONAL PSORIASIS FOUNDATION
NATIONAL REGISTRY FOR ICHTHYOSIS AND RELATED DISORDERS
NATIONAL VITILIGO FOUNDATION
NEVOID BASAL CELL CARCINOMA SYNDROME SUPPORT NETWORK
PACHYONYCHIA CONGENITA PROJECT
THE PSORIASIS ASSOC.
SCLERODERMA FEDERATION, INC.
SCLERODERMA FOUNDATION
SCLERODERMA RESEARCH FOUNDATION
THE SCLERODERMA SOCIETY
SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID)
SOCIETY FOR PEDIATRIC DERMATOLOGY (SPD)
THE STURGE-WEBER FOUNDATION
THE VITILIGO SOCIETY, U.K.
VITILIGO SUPPORT INTERNATIONAL
VZV RESEARCH FOUNDATION
XERODERMA PIGMENTOSUM SOCIETY
TABLE 55 DERMATOLOGICAL ASSOCIATIONS
STRATEGIC ALLIANCES IN THE DERMATOLOGY MARKET
MERGERS & ACQUISITIONS
TABLE 56 SIGNIFICANT MERGERS AND ACQUISITIONS (2005–2008)
VENTURE CAPITAL DEALS

Chapter- 7: REGULATORY PREVIEW

 

DRUG REGULATION IN THE UNITED STATES
LICENSES FOR MEDICAL DEVICES
DRUG REGULATION IN THE UNITED KINGDOM
LICENSES FOR DRUGS
DRUG AND EQUIPMENT APPROVAL IN EUROPE
LICENSES FOR MEDICAL EQUIPMENT
REIMBURSEMENT FOR DERMATOLOGICAL TREATMENT
REIMBURSEMENT IN THE UNITED STATES
REIMBURSEMENT IN EUROPE

Chapter- 8: MARKET METRICS

CHAPTER NINE: MARKET METRICS
MARKET TRENDS
BIG PHARMA’S FOCUS ON BLOCKBUSTER DRUGS ENABLES SPECIALTY FOCUS BY SMALL AND MEDIUM-SIZED FIRMS
COSMETIC/AESTHETIC DERMATOLOGY FACES DOWNTURN
CHANGES IN REIMBURSEMENT AND OTHER LEGISLATION ARE CREATING UNCERTAINTY
Managed Care Issues
Medical Liability
Physician Quality Reporting Initiative (PQRI)
Dermatologic Surgery
Cosmetic Procedure Tax
INCREASED USE OF GENERICS IN PRESCRIPTION DERMATOLOGY
DIFFICULTIES IN DETERMINATION OF BIOAVAILABILITY OF TOPICAL DRUGS
PHYSICIAN SHORTAGE AND PARAMEDIC INFLUX IN DERMATOLOGY
CERTIFICATION EXAM FOR NURSE PRACTITIONERS IN DERMATOLOGY NOW AVAILABLE
USE OF PROCEDURE-THERAPY AND SPECIFIC DRUGS IN DERMATOLOGY
POLLUTION CONTRIBUTES TO RISE IN ATOPIC DERMATITIS
MANUFACTURERS OF TNF-BLOCKER DRUGS ORDERED TO HIGHLIGHT RISK OF FUNGAL INFECTIONS
HIGHER CO-PAYS FOR BIOLOGICS IMPACTS PRESCRIPTIONS
U.S. DERMATOLOGICAL MARKET
TABLE 57 LEADING DRUGS PRESCRIBED BY OFFICE-BASED DERMATOLOGISTS - ALL INDICATIONS, 2008 (THOUSANDS)
PRESCRIPTION DATA FOR ACNE
FIGURE 3 PRESCRIBING OF ORAL ANTIBIOTICS FOR THE INTITIAL TREATMENT OF ACNE: CURRENT AND IN 1 YEAR (N=75)
FIGURE 4 PRESCRIBING OF TOPICAL ANTIBIOTICS/RETINOIDS FOR ACNE: CURRENT AND IN 1 YEAR (N=75)
TABLE 58 U.S. DERMATOLOGICAL THERAPEUTICS MARKET: REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013                ($ BILLIONS)
FIGURE 5 SHARE OF SEGMENTS IN U.S. PRESCRIPTION DERMATOLOGY MARKET, 2008 AND 2013 (%)
FIGURE 6 LEADING PRESCRIPTION DRUG REVENUES IN GLOBAL DERMATOLOGY MARKET, 2008 ($ MILLIONS)
ENBREL
FIGURE 7 ENBREL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 3,230 MILLION)
BOTOX
FIGURE 8 BOTOX SALES IN THE GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 1,200 MILLION
LOCERYL
FIGURE 9 LOCERYL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL = $350 MILLION
FIGURE 10 GLOBAL DERMATOLOGICAL PRESCRIPTION MARKET BY REGIONAL SHARE - FUTURE OUTLOOK, 2011 (%)
TABLE 59 MARKET SHARE OF PRESCRIPTION DRUG MANUFACTURERS, 2005–2007 ($ MILLIONS)
GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET
FIGURE 11 GLOBAL DERMATOLOGICAL MARKET BY REGIONAL SHARE, 2008 (%)
TABLE 60 GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013
FIGURE 12 GLOBAL PRESCRIPTION DERMATOLOGY MARKET SHARE BY SEGMENT, 2008 (%)

 

Warranty Information

Number of Pages: 198

Find Similar Products by Category

Currency Converter

Choose a currency below to display product prices in the selected currency.

United States US Dollars
Canada Canadian Dollars

Add to Wish List

Click the button below to add the Dermatological Therapeutics: Global Markets to your wish list.

Related Products